FDA tar­gets prod­ucts false­ly claim­ing to treat Alzheimer’s dis­ease

De­vel­op­ing treat­ments for Alzheimer’s dis­ease has been no­to­ri­ous­ly dif­fi­cult, and now the FDA is crack­ing down on com­pa­nies fraud­u­lent­ly claim­ing that their di­etary sup­ple­ments can help treat, pre­vent or even cure the dis­ease.

The FDA on Mon­day re­leased 12 warn­ing let­ters and five ad­vi­so­ry let­ters to for­eign and do­mes­tic com­pa­nies that are il­le­gal­ly sell­ing more than 58 un­ap­proved new drugs and/or mis­brand­ed drugs that claim to pre­vent, treat or cure Alzheimer’s dis­ease and a num­ber of oth­er se­ri­ous dis­eases and health con­di­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER